How cell and gene therapy developers can lessen the chances of receiving FDA complete response letters through the use of ...
Researchers at the Icahn School of Medicine at Mount Sinai in New York, Boston Medical Center, and Boston University ...
Delphi-2M is the first open source, large-scale model for predicting a patient’s disease risk and when it may occur.
Researchers at the Icahn School of Medicine at Mount Sinai in New York, Boston Medical Center, and Boston University ...